The glycogen synthase kinase (GSK) 3beta represses RNA polymerase I transcription
T Vincent1, A Kukalev, M Andäng
1Ludwig Institute for Cancer Research, Stockholm Branch, Karolinska Institutet, Stockholm, Sweden.
Abstract:
Several oncogenic proteins and tumour suppressors target the RNA polymerase I and interfere with rRNA synthesis. Here, we show that the glycogen synthase kinase (GSK) 3beta, which phosphorylates the tumour suppressor PTEN (phosphatase and tensin homologue deleted on chromosome 10), is selectively enriched in nucleoli of RAS-transformed cells. Immunoprecipitation and chromatin immunoprecipitation assays performed on epithelial and endothelial cells transformed with oncogenic RAS show that GSK3beta and PTEN are part of the same complex and associate with promoter and coding region of the rDNA. An active GSK3beta mutant abolished nucleolar BrUTP incorporation and associated with the member of the selectivity factor 1 complex TAF(I)110. Finally, GSK3beta inhibition upregulated 45S, 18S and 28S rRNA synthesis in RAS-transformed epithelial cells as revealed by semiquantitative real-time PCR and promoted cellular proliferation. Our results underscore a repressive function for GSK3beta in rRNA biogenesis supporting its role as a tumour supressor.
Insights
Glycogen synthase kinase 3 beta (GSK3beta) is enriched in nucleoli of RAS-transformed cells, where it represses ribosomal RNA (rRNA) synthesis. Inhibiting GSK3beta promotes rRNA synthesis and cell proliferation, supporting its tumor suppressor role.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- Oncogenic proteins and tumor suppressors can target RNA polymerase I, affecting ribosomal RNA (rRNA) synthesis.
- PTEN (phosphatase and tensin homologue deleted on chromosome 10) is a tumor suppressor phosphorylated by GSK3beta.
Purpose of the Study:
- To investigate the role of glycogen synthase kinase 3 beta (GSK3beta) in RAS-transformed cells.
- To elucidate the mechanism by which GSK3beta influences rRNA synthesis and cell proliferation.
Main Methods:
- Immunoprecipitation and chromatin immunoprecipitation assays were used to study protein complexes and DNA association.
- Quantitative real-time PCR was employed to measure rRNA synthesis.
- Cellular proliferation assays were conducted.
Main Results:
- GSK3beta is selectively enriched in nucleoli of RAS-transformed cells.
- GSK3beta and PTEN form a complex that associates with rDNA.
- Active GSK3beta mutant abolished nucleolar rRNA synthesis and associated with TAF(I)110.
- GSK3beta inhibition upregulated rRNA synthesis and promoted proliferation in RAS-transformed cells.
Conclusions:
- GSK3beta plays a repressive role in rRNA biogenesis.
- These findings support a tumor suppressor function for GSK3beta in the context of RAS-driven cancers.
Related Concept Videos
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Eukaryotic RNA Polymerases
All three eukaryotic RNAPs require specific transcription factors, of which the...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Transcription Initiation
The promoters and enhancers and their accessory proteins allow tight regulation of...


